177 related articles for article (PubMed ID: 15105956)
1. Mycotoxins and antifungal drug interactions: implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures.
Anyanwu EC; Campbell AW; Ehiri JE
ScientificWorldJournal; 2004 Mar; 4():167-77. PubMed ID: 15105956
[TBL] [Abstract][Full Text] [Related]
2. Application, effectiveness, and limitations of the electrophysiological diagnosis of neurotoxic effects of chronic environmental mycotoxins in humans.
Anyanwu E; Ehiri J; Akpan AI
Int J Adolesc Med Health; 2004; 16(2):107-18. PubMed ID: 15266990
[TBL] [Abstract][Full Text] [Related]
3. Health effects of mycotoxins in indoor air: a critical review.
Robbins CA; Swenson LJ; Nealley ML; Gots RE; Kelman BJ
Appl Occup Environ Hyg; 2000 Oct; 15(10):773-84. PubMed ID: 11036728
[TBL] [Abstract][Full Text] [Related]
4. Adverse human health effects associated with molds in the indoor environment.
Hardin BD; Kelman BJ; Saxon A
J Occup Environ Med; 2003 May; 45(5):470-8. PubMed ID: 12762072
[TBL] [Abstract][Full Text] [Related]
5. Analysis for mycotoxins: the chemist's perspective.
Jarvis BB
Arch Environ Health; 2003 Aug; 58(8):479-83. PubMed ID: 15259427
[TBL] [Abstract][Full Text] [Related]
6. Mycotoxins as harmful indoor air contaminants.
Jarvis BB; Miller JD
Appl Microbiol Biotechnol; 2005 Jan; 66(4):367-72. PubMed ID: 15565335
[TBL] [Abstract][Full Text] [Related]
7. The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures.
Anyanwu E; Campbell AW; Jones J; Ehiri JE; Akpan AI
ScientificWorldJournal; 2003 Nov; 3():1128-37. PubMed ID: 14625399
[TBL] [Abstract][Full Text] [Related]
8. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
Vojdani A; Kashanian A; Vojdani E; Campbell AW
Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):595-614. PubMed ID: 14686801
[TBL] [Abstract][Full Text] [Related]
9. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.
Hope J
ScientificWorldJournal; 2013; 2013():767482. PubMed ID: 23710148
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
Vojdani A; Campbell AW; Kashanian A; Vojdani E
Arch Environ Health; 2003 Jun; 58(6):324-36. PubMed ID: 14992307
[TBL] [Abstract][Full Text] [Related]
11. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective.
Kuhn DM; Ghannoum MA
Clin Microbiol Rev; 2003 Jan; 16(1):144-72. PubMed ID: 12525430
[TBL] [Abstract][Full Text] [Related]
12. Health effects of indoor molds.
Burr ML
Rev Environ Health; 2001; 16(2):97-103. PubMed ID: 11512632
[TBL] [Abstract][Full Text] [Related]
13. The role of Stachybotrys mycotoxins in building-related illness.
Page EH; Trout DB
AIHAJ; 2001; 62(5):644-8. PubMed ID: 11669391
[TBL] [Abstract][Full Text] [Related]
14. Molds and mycotoxins in indoor environments--a survey in water-damaged buildings.
Bloom E; Nyman E; Must A; Pehrson C; Larsson L
J Occup Environ Hyg; 2009 Nov; 6(11):671-8. PubMed ID: 19757292
[TBL] [Abstract][Full Text] [Related]
15. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure.
Empting LD
Toxicol Ind Health; 2009; 25(9-10):577-81. PubMed ID: 19854819
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes.
Ratnaseelan AM; Tsilioni I; Theoharides TC
Clin Ther; 2018 Jun; 40(6):903-917. PubMed ID: 29880330
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of mycotoxins, intracellular functions of vitamin B12, and neurological manifestations in patients with chronic toxigenic mold exposures. A review.
Anyanwu EC; Morad M; Campbell AW
ScientificWorldJournal; 2004 Aug; 4():736-45. PubMed ID: 15349513
[TBL] [Abstract][Full Text] [Related]
18. Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure to molds compared to 100 exposed to chemicals.
Kilburn KH
Toxicol Ind Health; 2009; 25(9-10):681-92. PubMed ID: 19793776
[TBL] [Abstract][Full Text] [Related]
19. A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin.
Rea WJ
Clin Ther; 2018 Jun; 40(6):889-893. PubMed ID: 29861191
[TBL] [Abstract][Full Text] [Related]
20. Effects of toxic exposure to molds and mycotoxins in building-related illnesses.
Rea WJ; Didriksen N; Simon TR; Pan Y; Fenyves EJ; Griffiths B
Arch Environ Health; 2003 Jul; 58(7):399-405. PubMed ID: 15143852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
